{'fraction_non_alphanumeric': 0.03827751196172249, 'fraction_numerical': 0.008202323991797676, 'mean_word_length': 4.566539923954372, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.

PURPOSE
We previously reported a higher frequency of c-Met protein expression and high proliferative status in gastric cancers producing alpha-fetoprotein (AFP) than in those not producing AFP.


METHODS
To investigate this further, we established an AFP-producing gastric cancer cell line, designated as AME-1, from the primary tumor of a patient with AFP-producing gastric cancer.


RESULTS
alpha-Fetoprotein production in the AME-1 cell line was confirmed at the protein level by immunocytochemistry and at the mRNA level by reverse transcription-polymerase chain reaction (RT-PCR). A high amount of AFP was also detected in the supernatant of cultured AME-1. The AME-1 cell line expressed c-Met both at the mRNA and protein levels. A semiquantitative RT-PCR method indicated that AME-1 had a higher amount of c-Met mRNA than well-known gastric cancer cell lines (MKN-28, MKN-45) with strong c-Met expression. Hepatocyte growth factor (HGF), a ligand for the c-Met receptor, was not detected in the mRNA or protein of AME-1. The AME-1 cell line showed a proliferative response to exogenous HGF treatment in a dose-dependent manner, but the activity of migration was not stimulated by exogenous HGF.


CONCLUSIONS
The AME-1 cell line may be a useful model for elucidating aggressive behavior, especially related to regulation of the c-Met/HGF system, in AFP-producing gastric cancers.